Generics sales volume

Global sales of proprietary drugs were 505 billion in 2005, or more than 90% of the total pharma market. With a share of 45%, the United States has by far the single largest market. Global sales of generics were about 45 billion in 2005 (except China and India), or less than 10% of the total pharma market. Obviously, the difference in production volumes is smaller. 

Medium pharma 50-100 Sales 0.5- 5 billion, regional reach, <300 m reactor volume, limited R D capabilities, mainly unlicensed drugs and generics. Barr, Forest, Sepracor, USA Altana, Merck, Stada, Germany Sankyo, Japan Dr Reddy s, Ranbaxy, India... 

The total value of medicine sold comprises approximately 1 percent of the total world market (80 percent of the volume of medicine purchased by the State represents only 20 percent in sales). When the use of generic medicines by the State is taken into account, the generic market is large. 

Manufacturers continue to increase the real price of their drugs as their share of the market in unit volume falls. The real price increases dampen the rapid decline in unit sales that follows generic competition. Even with a very large price discrepancy between generic... 

---